Med. praxi. 2018;15(1):6-8 | DOI: 10.36290/med.2018.002

Possible kidney injury in association with the use of common anti-infective agents

MUDr. Jan Vachek, PhDr. MUDr. Oskar Zakiyanov, Ph.D., prof. MUDr. Vladimír Tesař, DrSc.
Klinika nefrologie VFN a 1. LF UK, Praha

Kidney injury is among frequent complications of pharmacotherapy in both outpatients and inpatients. Although it most often isa condition that is usually asymptomatic and resolves spontaneously without developing serious sequelae, in some cases it maylead to temporary or permanent loss of renal function and the need for replacement of renal function. In hospitalized patients,in particular, acute kidney injury is associated with high morbidity and mortality. This paper presents a review of potential nephrotoxicityof common anti-infective agents with respect to the needs of a specialist in outpatient practice.

Keywords: acute kidney injury (AKI), nephrotoxicity, anti-infective agents

Published: March 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vachek J, Zakiyanov O, Tesař V. Possible kidney injury in association with the use of common anti-infective agents. Med. praxi. 2018;15(1):6-8. doi: 10.36290/med.2018.002.
Download citation

References

  1. Schwarz A, Krause PH, Kunzendorf U, et al. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol. 2003; 54: 179-190.
  2. Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012; 81: 819-825. Go to original source... Go to PubMed...
  3. Bonventre JV, Vaidya VS, Schmouder R, et al. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010; 28: 436-440. Go to original source... Go to PubMed...
  4. Karow T, Lang-Roth R. Allgemeine und spezielle Pharmakologie und Toxikologie. 25. Aufl. Dr. Karow - Eigenverlag, Pulheim 2017.
  5. Verbeke F, Lindley E, Van Bortel L, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant. 2014; 29: 490-496. Go to original source... Go to PubMed...
  6. Nyman HA. Renal dosing in high-risk populations. J Infus Nurs. 2015; 38: 210-215. Go to original source... Go to PubMed...
  7. Ma TK, Chow KM, Choy AS, et al. Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients. Clin Kidney J. 2014; 7: 507-512. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.